Asahi Life Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,280
| Closed | -$515K | – | 222 |
|
|
2024
Q4 | $515K | Buy |
+1,280
| New | +$515K | 0.31% | 60 |
|
|
2024
Q2 | – | Sell |
-560
| Closed | -$234K | – | 221 |
|
|
2024
Q1 | $234K | Buy |
+560
| New | +$234K | 0.14% | 162 |
|
|
2023
Q4 | – | Sell |
-555
| Closed | -$193K | – | 237 |
|
|
2023
Q3 | $193K | Sell |
555
-885
| -61% | -$308K | 0.07% | 170 |
|
|
2023
Q2 | $507K | Sell |
1,440
-65
| -4% | -$22.9K | 0.17% | 63 |
|
|
2023
Q1 | $474K | Buy |
+1,505
| New | +$474K | 0.15% | 75 |
|
|
2022
Q3 | – | Sell |
-1,455
| Closed | -$410K | – | 309 |
|
|
2022
Q2 | $410K | Sell |
1,455
-285
| -16% | -$80.3K | 0.11% | 76 |
|
|
2022
Q1 | $454K | Sell |
1,740
-895
| -34% | -$234K | 0.06% | 106 |
|
|
2021
Q4 | $579K | Buy |
2,635
+150
| +6% | +$33K | 0.07% | 75 |
|
|
2021
Q3 | $451K | Sell |
2,485
-80
| -3% | -$14.5K | 0.06% | 89 |
|
|
2021
Q2 | $517K | Buy |
2,565
+400
| +18% | +$80.6K | 0.07% | 78 |
|
|
2021
Q1 | $465K | Sell |
2,165
-350
| -14% | -$75.2K | 0.06% | 104 |
|
|
2020
Q4 | $594K | Buy |
2,515
+475
| +23% | +$112K | 0.08% | 87 |
|
|
2020
Q3 | $555K | Buy |
+2,040
| New | +$555K | 0.08% | 65 |
|
|
2019
Q4 | – | Sell |
-1,600
| Closed | -$271K | – | 276 |
|
|
2019
Q3 | $271K | Buy |
+1,600
| New | +$271K | 0.04% | 142 |
|
|
2019
Q1 | – | Sell |
-3,550
| Closed | -$588K | – | 230 |
|
|
2018
Q4 | $588K | Buy |
+3,550
| New | +$588K | 0.09% | 61 |
|